Health & Medicine
The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.
Heartburn or Heart Trouble? When Reflux Symptoms Warrant a Doctor's Visit
Two Israeli gastroenterologists explain when heartburn signals reflux disease or serious problems, its causes including hiatal hernia and obesity, and a possib…
MediumNational team deploys to Gujarat to combat Chandipura virus outbreak
India's ICMR has deployed a national team to Gujarat to investigate and control a Chandipura virus outbreak linked to acute encephalitis syndrome. The response…
HighKelowna clinical trial seeks volunteers for novel RSV vaccine study
Okanagan Clinical Trials is recruiting volunteers for a study testing a novel single-dose RSV vaccine for older adults, addressing a virus that kills an estima…
MediumGenetic variants linked to severe COVID-19 also tied to diabetes, blood clots
A study of 658,000 military veterans reveals genetic variants associated with severe COVID-19 also link to COPD, diabetes, blood clots, and heart disease, sugg…
HighRFK Jr. Advances Vaccine Policy Changes as Health Secretary
RFK Jr., now in a health leadership position, is advancing goals aligned with anti-vaccine groups, including establishing a vaccine injury clinic and modifying…
HighAstraZeneca seeks FDA approval for first at-home self-administered flu vaccine
AstraZeneca requested FDA approval to allow adults to self-administer its nasal flu vaccine FluMist at home, which would be the first self-administered vaccine…
HighUS surgeon airlifted to Germany after contracting Ebola in DRC outbreak
A US surgeon contracted Ebola while treating patients in Congo and was evacuated to Germany for treatment. The outbreak has spread to urban areas with 600+ sus…
High1 in 20 Australian Women Now Receiving IV Iron Infusions
One in 20 Australian women now receive intravenous iron infusions, marking a significant decade-long increase in this treatment approach, according to Flinders…
HighVietnam receives 2M Moderna doses as COVID outbreak surges
Vietnam received 2 million Moderna vaccine doses from the U.S. via COVAX as it battles its worst COVID-19 outbreak with record daily infections exceeding 1,800…
HighDiabetic drugs show promise for weight loss, but remain costly and limited in India
GLP1 receptor agonists and SGLT2 inhibitors, originally developed for diabetes, are proving effective for weight loss by removing glucose via urinary excretion…
HighLIG1 Loss Offers New Drug Combination Strategy for Aggressive Breast Cancer
Researchers identified that loss of the LIG1 gene in aggressive triple-negative breast cancers creates a vulnerability exploitable with a combination of PARP a…
HighEbola outbreak in DRC spirals as violence, aid cuts, and community anger hamper response
Suspected Ebola cases in DRC's eastern Congo exceed 900 with over 200 deaths, as health facilities face attacks from angry communities amid rebel violence, dis…
HighNigeria confirms first Ebola case; patient arrived from Uganda
Nigeria confirms an Ebola case in a female patient who traveled from Uganda, marking the virus's spread to a fourth African country amid the ongoing Bundibugyo…
HighStudy links chronic inflammation to long COVID, sparks clinical trial of eczema drug
Researchers at Beth Israel Deaconess Medical Center identified chronic inflammation as a key factor in long COVID, prompting a clinical trial of an eczema drug…
HighGuinea declares new Ebola outbreak as cases emerge near Liberia border
Guinea declared a new Ebola outbreak after three deaths and four illnesses in the southeast, marking the first resurgence since the devastating 2013-2016 West…
HighExperimental Alzheimer's drug restores memory in mouse studies, heads to human trials
An experimental drug GL-II-73 demonstrated ability to restore memory and reverse cognitive decline in Alzheimer's mouse models, with human clinical trials expe…
HighSemaglutide patent expiry could slash Indian weight-loss drug costs by 70%
Semaglutide's patent expiration in India on March 20 enables generic manufacturers to enter the weight-loss drug market, potentially reducing prices by 50-70%…
HighFour Ebola Nurses Recover in DRC as Treatment Trials Advance
Four nurses recovered from Ebola in DR Congo as outbreak response intensifies, with five total recoveries reported despite 210 confirmed cases and 17 deaths fr…
HighIndia Cuts Cancer Drug Prices After Supreme Court Condemns Hospital Mark-Ups as 'Extortion'
India's government is cutting prices of 137 cancer drugs after the Supreme Court condemned hospital and retailer mark-ups as extortion, a case brought by a Ker…
HighFDA Expands Myocarditis Warnings on COVID-19 Vaccines Amid Leadership Shift
The FDA has expanded warnings about myocarditis, a rare heart inflammation linked to COVID-19 vaccines, affecting 8 cases per 1 million people ages 6 months to…
HighEbola outbreak in Congo faces dual crisis: rare virus and attacks on aid workers
A rare Bundibugyo Ebola outbreak in eastern Congo nears 1,000 suspected cases while aid workers face violent attacks and community skepticism, complicating con…
HighEbola spread in DR Congo 'deeply alarming' as cases surge past 1,000
MSF warns of unprecedented rapid Ebola spread in DR Congo with over 1,000 suspected cases and 246 deaths within two weeks, citing containment efforts lagging b…
HighThree female scientists lead Northern Ireland's fight against heart disease
Three female scientists in Northern Ireland are leading groundbreaking cardiovascular research, from statin tolerance studies to stem cell therapies, potential…
HighMedical Expert Warns of Tirzepatide Risks, Emphasizes Need for Professional Oversight
A Brazilian university hosted a lecture on tirzepatida weight-loss injections, emphasizing their clinical benefits for obesity treatment while warning against…
HighD3 Bio's D3S-001 Wins FDA Breakthrough Therapy Status for KRAS G12C Lung Cancer
D3 Bio announced FDA Breakthrough Therapy and Orphan Drug designations for D3S-001, a next-generation KRAS G12C inhibitor targeting lung and colorectal cancers…
HighEU Regulator Recommends Authorization of Pfizer's COVID-19 Antiviral Pill
The European Medicines Agency recommended authorization of Pfizer's Paxlovid pill for COVID-19 treatment in the EU, marking the first approved oral antiviral f…
HighOzempic: Riesgos crecientes por uso estético sin supervisión médica
Ozempic, originally for diabetes treatment, faces safety concerns as off-label cosmetic use surges without medical supervision, with FDA reporting 66,000+ adve…
HighGLP-1 drugs show dose-dependent benefits: greater weight loss yields lower obesity-related disease risk
Real-world study of 89,718 patients shows GLP-1 treatments reduce risks of osteoarthritis, kidney disease, and sleep apnea proportionally to weight loss achiev…
HighGLP-1 drugs show promise in slowing biological aging, study finds
Randomized clinical trials show semaglutide, a GLP-1 drug, slows biological aging markers in adults with HIV by 9%, with potential implications for broader agi…
HighHantavirus outbreak on Atlantic cruise kills 3, sickens 6 others, WHO confirms
WHO confirms one hantavirus case and five suspected cases aboard an Atlantic cruise vessel, with three deaths and one critical patient. Investigations ongoing…
HighDual-drug combo shows promise against osteosarcoma in preclinical study
St. Jude researchers identified a combination approach targeting EP300 and AKT that slowed osteosarcoma growth and prolonged survival in preclinical models, of…
HighResearchers identify 15-PGDH enzyme as potential Parkinson's disease treatment target
Researchers identified that inhibiting the enzyme 15-PGDH protects brain cells in Parkinson's disease models by reducing harmful inflammation and oxidative str…
HighStudy exposes racial disparities in hepatitis C testing and treatment for reproductive-aged women
Study reveals racial disparities in hepatitis C testing and treatment for reproductive-aged women with opioid use disorder, with fewer than 10% receiving treat…
HighFDA Approves GSK's Hibsago, First Antisense Drug for Chronic Hepatitis B, Offering Path Off Lifelong Treatment
The US FDA approved GSK's Hibsago (bepirovirsen), the first antisense oligonucleotide approved for chronic hepatitis B, offering a possible path to control the…
HighFDA Expands Access to Promising Pancreatic Cancer Drug Daraxonrasib
The FDA has granted early access to daraxonrasib, a promising new drug for pancreatic cancer, one of the deadliest malignancies. The authorization expands trea…
HighB.C. clamps down on Ozempic exports as U.S. demand threatens Canadian drug supplies
B.C. restricts Ozempic sales to non-residents after Americans purchased 15% of prescriptions, threatening Canadian supply. Federal action sought to prevent mas…
HighDoctor Shares Key Advice for Supporting Breast Cancer Patients
Dr. Elisa Port shares patient-informed advice on supporting breast cancer patients and prevention strategies, emphasizing individualized care and the importanc…
HighWHO declares Ebola outbreak in Congo and Uganda a global health emergency
The WHO declared an Ebola outbreak caused by the rare Bundibugyo virus in Congo and Uganda a global health emergency after 300+ suspected cases and 88 deaths,…
HighPennsylvania measles outbreak nears 400 cases as virus spreads beyond Lancaster County
Pennsylvania has confirmed nearly 400 measles cases in 2024, including the first deaths in over 30 years, with the outbreak concentrated in Lancaster County an…
HighDaraxonrasib nearly doubles survival in advanced pancreatic cancer, targeting previously 'undruggable' KRAS mutation
A new drug called daraxonrasib nearly doubles survival rates in metastatic pancreatic cancer by targeting the KRAS mutation that drives 90% of cases, offering…
HighAustralia begins COVID-19 vaccination rollout as first Pfizer doses arrive
Australia receives its first 4,000 Pfizer COVID-19 vaccine doses, with Prime Minister Scott Morrison and aged care residents among the first to be vaccinated.…
HighWHO convenes experts to advance Ebola treatments and vaccines for Bundibugyo outbreak
WHO has assembled expert panels to evaluate candidate treatments and vaccines for Bundibugyo ebolavirus, with mRNA vaccine candidates showing promise and Gavi…
HighCancer: The global epidemic reshaping humanity's future
Cancer has become one of humanity's greatest medical challenges, killing more people annually than HIV/AIDS, tuberculosis and malaria combined, with projection…
HighOral GLP-1 pill achieves nearly 12% weight loss in 36-week trial
A new oral GLP-1 medication demonstrated nearly 12% weight loss over 36 weeks in clinical trials, marking progress in oral obesity treatment alternatives to in…
HighModerna-Merck cancer vaccine shows promise, but hype outpaces evidence
Moderna and Merck announced a significant cancer vaccine trial success using mRNA technology, though experts caution that market hype may outpace clinical evid…
HighWHO declares Ebola emergency as rare Bundibugyo variant spreads across Congo and Uganda
WHO declared the Ebola outbreak in Democratic Republic of Congo and Uganda a global public health emergency after 300+ suspected cases and 88 deaths, caused by…
HighDaraxonrasib offers new hope for pancreatic cancer patients in clinical trials
A new drug called daraxonrasib shows promise as a breakthrough treatment for pancreatic cancer, one of the deadliest malignancies, with oncologists calling it…
HighAppeals Court Blocks Mifepristone Mail Distribution Nationwide
A federal appeals court blocked mifepristone mail distribution nationwide, restoring in-person dispensing requirements and setting up a likely Supreme Court ba…
HighAI Accelerates Precision Cancer Drug Delivery Through Nanomedicine Design
AI is revolutionizing nanomedicine design for cancer treatment by predicting nanoparticle behavior, optimizing drug delivery, and enabling personalized therapi…
HighExperimental pill nearly doubles survival for advanced pancreatic cancer
Daraxonrasib, a novel pill targeting mutated KRAS proteins, nearly doubled survival time for advanced pancreatic cancer patients in a major clinical trial, off…
High